| Financial Year |
March 31 2023 |
| Monetary Funds |
2,326,772,418.03 |
| Held-for-trading Financial Assets |
433,287,419.35 |
| Notes Receivable |
-- |
| Accounts Receivable |
557,772,568.45 |
| Advances to Suppliers |
33,564,435.50 |
| Other Receivables |
22,705,058.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
526,578,443.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
546,526,063.81 |
| Total Current Assets |
4,571,226,413.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
294,387,233.09 |
| Investment Properties |
31,618,266.90 |
| Fixed Assetes |
1,419,934,601.74 |
| Under-construction Projects |
42,996,646.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
922,896,799.08 |
| R&D expenses |
1,309,995,411.15 |
| Goodwill |
60,527,206.59 |
| Long-Term Deferred and Prepaid Expenses |
117,713,710.75 |
| Deferred Income Tax Assets |
87,479,807.32 |
| Other Non-Current Assets |
325,200,701.64 |
| Sub-Total of Non-Current Assets |
5,099,303,677.90 |
| Total Assets |
9,670,530,091.05 |
| Short-Term Loans |
60,548,641.67 |
| Trading Financial liabilities |
2,207,108.68 |
| Notes Payable |
35,309,750.00 |
| Accounts Payable |
167,946,677.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
143,007,767.00 |
| Taxes Payable |
65,439,275.24 |
| Interest Payable |
-- |
| Dividend Payable |
190,489.44 |
| Other payables |
351,781,412.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,716,841.73 |
| Other Current Liabilities |
428,982,867.40 |
| Sub-Total of Current Liabilities |
1,319,341,733.38 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
26,391,443.49 |
| Other Non-Current Liabilities |
28,996,797.57 |
| Sub-Total of Non-Current Liabilities |
164,933,735.75 |
| Total Liabilities |
1,484,275,469.13 |
| Paid-In Capital(Or Share Stock) |
1,114,816,535.00 |
| Capital Surplus |
1,872,614,213.76 |
| Surplus Reserve |
526,364,058.63 |
| LESS:Treasury Stock |
602,164,494.80 |
| Undistributed Profits |
5,213,988,534.45 |
| Minority Stockholder's Interest |
35,190,819.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,151,063,802.50 |
| Owner's Equity（Stockholder's Equity） |
8,186,254,621.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,670,530,091.05 |
